Answers are grounded in this paper and cite their sources.
Real-world practice examines anifrolumab treatment outcomes in lupus erythematosus, indicating potential benefits for patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Muntaner‐Virgili et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: